Exactus Inc logo

EXDI - Exactus Inc Share Price

$0.067 0.0  40.0%

Last Trade - 30/09/20

Sector
Healthcare
Size
Micro Cap
Market Cap £1.93m
Enterprise Value £1.81m
Revenue £1.21m
Position in Universe 6025th / 6411
Bullish
Bearish
Unlock EXDI Revenue
Momentum
Relative Strength (%)
1m -32.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -94.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.001 0.000 0.000 0.000 0.000 0.35 +232.5%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Exactus Inc revenues increased from $156K to $1.4M. Net loss applicable to common stockholders increased 30% to $4.2M. Revenues reflect Net revenues - related party increase from $41K to $316K. Higher net loss reflects Interest Expense increase of 92% to $709K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.14 to -$0.09.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

EXDI Revenue Unlock EXDI Revenue

Net Income

EXDI Net Income Unlock EXDI Revenue

Normalised EPS

EXDI Normalised EPS Unlock EXDI Revenue

PE Ratio Range

EXDI PE Ratio Range Unlock EXDI Revenue

Dividend Yield Range

EXDI Dividend Yield Range Unlock EXDI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
EXDI EPS Forecasts Unlock EXDI Revenue
Profile Summary

Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated January 18, 2008
Public Since November 24, 2015
No. of Shareholders: 157
No. of Employees: 4
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OTC Markets Group
Shares in Issue 52,200,104
Free Float (0.0%)
Eligible for
ISAs
SIPPs
EXDI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for EXDI
Upcoming Events for EXDI
Frequently Asked Questions for Exactus Inc
What is the Exactus Inc share price?

As of 30/09/20, shares in Exactus Inc are trading at $0.067, giving the company a market capitalisation of £1.93m. This share price information is delayed by 15 minutes.

How has the Exactus Inc share price performed this year?

Shares in Exactus Inc are currently trading at $0.067 and the price has moved by -92.58% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Exactus Inc price has moved by -93.16% over the past year.

What are the analyst and broker recommendations for Exactus Inc?

There are no analysts currently covering Exactus Inc.

When will Exactus Inc next release its financial results?

Exactus Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Exactus Inc dividend yield?

Exactus Inc does not currently pay a dividend.

Does Exactus Inc pay a dividend?

Exactus Inc does not currently pay a dividend.

When does Exactus Inc next pay dividends?

Exactus Inc does not currently pay a dividend.

How do I buy Exactus Inc shares?

To buy shares in Exactus Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Exactus Inc?

Shares in Exactus Inc are currently trading at $0.067, giving the company a market capitalisation of £1.93m.

Where are Exactus Inc shares listed? Where are Exactus Inc shares listed?

Here are the trading details for Exactus Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: EXDI
What kind of share is Exactus Inc?

Based on an overall assessment of its quality, value and momentum, Exactus Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Exactus Inc share price forecast 2020?

We were not able to load any forecast data for Exactus Inc.

How can I tell whether the Exactus Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Exactus Inc. Over the past six months, the relative strength of its shares against the market has been -65.44%. At the current price of $0.067, shares in Exactus Inc are trading at -74.31% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Exactus Inc PE Ratio?

We were not able to find PE ratio data for Exactus Inc.

Who are the key directors of Exactus Inc?

Exactus Inc's management team is headed by:

Timothy Ryan - EVP
Kevin Esval - IND
Jeffrey Thompson - IND
Kenneth Puzder - CFO
John Price - IND
Emiliano Aloi - CEO
James Sposato - CIO
Daniel Alberttis - DRC
Alvaro Alberttis - DRC
Julian Pittam - CHM
Who are the major shareholders of Exactus Inc?

Here are the top five shareholders of Exactus Inc based on the size of their shareholding:

Ceed2Med LLC Corporation
Percentage owned: 12.4% (6.44m shares)
Wert (Lawrence J) Individual Investor
Percentage owned: 7.44% (3.86m shares)
Du (Chesne Derek) Individual Investor
Percentage owned: 1.93% (1,000k shares)
Johnson (Andrew L) Individual Investor
Percentage owned: 0.58% (300k shares)
Puzder (Kenneth E) Individual Investor
Percentage owned: 0.48% (250k shares)
Similar to EXDI
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.